vs
Side-by-side financial comparison of Brainsway Ltd. (BWAY) and TELEFLEX INC (TFX). Click either name above to swap in a different company.
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $-401.9M | ||
| Q3 25 | — | $913.0M | ||
| Q2 25 | — | $780.9M | ||
| Q1 25 | — | $700.7M | ||
| Q4 24 | — | $795.4M | ||
| Q3 24 | — | $764.4M | ||
| Q2 24 | — | $749.7M | ||
| Q1 24 | — | $737.8M |
| Q4 25 | — | $-714.3M | ||
| Q3 25 | — | $-408.9M | ||
| Q2 25 | — | $122.6M | ||
| Q1 25 | — | $95.0M | ||
| Q4 24 | — | $-136.7M | ||
| Q3 24 | — | $111.0M | ||
| Q2 24 | — | $80.0M | ||
| Q1 24 | — | $15.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 49.5% | ||
| Q2 25 | — | 55.2% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 55.3% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.6% | ||
| Q1 24 | — | 56.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | — | -13.9% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 15.6% | ||
| Q1 24 | — | -0.6% |
| Q4 25 | — | 177.8% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | — | 14.5% | ||
| Q2 24 | — | 10.7% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | $-15.85 | ||
| Q3 25 | — | $-9.24 | ||
| Q2 25 | — | $2.77 | ||
| Q1 25 | — | $2.07 | ||
| Q4 24 | — | $-2.89 | ||
| Q3 24 | — | $2.36 | ||
| Q2 24 | — | $1.69 | ||
| Q1 24 | — | $0.32 |
